AzTrials
AzTrials

Prevention, Arterial HypertensionSocialCorNCT04944472

Possibilities of Perceiving Information on the Primary Prevention of Cardiovascular Diseases in Persons Suffering From Essential Hypertension Through a Social Network

An observational study of Prevention, Arterial Hypertension, run by Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department at 1 site in Russia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized, prospective study conducted on the basis of a social network (Instagram platform), two-stage. At the first stage, the online school "Save Your Heart" was announced and 945 applicants were enrolled in the training. Read more about this study

Who is it for?
Any age
Conditions the study is for
Prevention, Arterial Hypertension
What is being tested?
HDKQ questionnaire
How many people
125 participants
Where
1 siteRussia
Study dates
1 Feb 2021to 31 Mar 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: The total number of people who listened to and read the material of the online school was 2108 people, the total involvement (comments, reposts, saving the material) was 1598 people. The average percentage of watching videos is 22%. The audience of the online school is mostly female (84%), with an average age of 45.9 ± 12.3 years. 80.8% of the participants had higher than secondary education.

Who may be able to join

  • Having a diagnosis of arterial hypertension
  • Informed consent signed by the respondent.

Who cannot join

  • 1. No diagnosis of arterial hypertension

Trial locations and contacts

1 site in 1 country.

Russia1 site
  • Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department

    Moscow

Other trials in Russia

About this study

Official title: Opportunities for the Perception of Information on the Primary Prevention of Cardiovascular Diseases in Persons Suffering From Hypertension Through the Social Network Instagram

A randomized, prospective study conducted on the basis of a social network (Instagram platform), two-stage. At the first stage, the online school "Save Your Heart" was announced and 945 applicants were enrolled in the training. The online school curriculum consisted of the following blocks: "Risk Factors for Cardiovascular Diseases (CVD)", "Healthy Nutrition for the Heart", "Cholesterol. What is important for the patient to know? "," Physical activity for the prevention of CVD "," Overweight and obesity "," Smoking as a risk factor for CVD "," AH: diagnosis "," AH: treatment "," Myocardial infarction: diagnosis and treatment". At the 2nd stage, 125 participants were selected by random randomization, then distributed into 4 training groups to provide training materials: group 1 (n = 31) - then text publications up to 4 thousand characters, group 2 (n = 31) - short video clips up to 5 minutes, group 3 (n = 33) - first text publications, then video clips, group 4 (n = 30) - video clips, then text publications. Before and after school, respondents from all four groups completed the HDKQ questionnaire.

Read the detailed description

To study the potential of the Instagram social network in increasing the medical literacy of people with essential hypertension and to develop methodological approaches to informing the population about the primary prevention of cardiovascular diseases through social networks, including hypertension.

  1. To assess the level of knowledge about risk factors and cardiovascular diseases among users of social networks with essential hypertension.
  2. Conduct a comparative assessment of the impact of the type of information materials for patients in social networks (Group I - text, Group II - video, Group III - video + text, Group IV - text + video) on the level of its understanding and assimilation by persons with essential hypertension.
  3. To study the possibilities of perceiving information on the primary prevention of cardiovascular diseases, depending on the gender, age and social status of users of social networks suffering from hypertension.

The research site is the social network Instagram, 4 new accounts will be created to complete the assigned tasks.

An adapted HDKQ (Heart Disease Knowledge Questionnaire) with additional gender, age and social status questions will be sent to those eligible for inclusion before the start of the educational program. Respondents to the questions of the questionnaire should be sent in text format to the private messages of the project account.

The format of interaction with the audience includes 8 text publications up to 4 thousand characters and 8 video publications up to 5 minutes long.

Text and video publications will be identical in terms of text content, and they will also reflect the answers to each question of the HDKQ questionnaire.

Publication topics:

  1. Risk factors for cardiovascular disease.
  2. Healthy food for the heart.
  3. "Good" and "bad" cholesterol. What is important to know?
  4. Physical activity. How much movement does it take to keep your heart healthy?
  5. Overweight and obesity.
  6. Smoking as a risk factor for cardiovascular diseases.
  7. Hypertension: diagnosis, treatment goals.
  8. Myocardial infarction is one of the most formidable cardiovascular complications.

All participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status:

in group I, project participants will only be presented with video publications on each of the declared topics (8 in total), in group II - only text publications (total 8), in group III - first text publications, and then video publications (16 in total), in group IV - first video publications, and then text publications (16 in total).

Upon completion of the educational program, participants will again be asked to answer the questions of the adapted HDKQ (Heart Disease Knowledge Questionnaire) questionnaire.

Being tested
HDKQ questionnaire
Keywords
digital prevention, primary prevention, secondary prevention, hypertension, patient education, social media
Medical subject headings
Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HDKQ questionnaireBehavioural

    Studying the possibilities of perceiving information on the primary prevention of cardiovascular diseases in persons suffering from hypertension through the social network Instagram

Study groups in NCT04944472
Study groupRoleWhat they receive
group IAll participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status: in group I, project participants will only be presented with video publications on each of the declared topics (8 in total).
Receives: Behavioral: HDKQ questionnaire
group IIAll participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status: in group II - only text publications (total 8).
Receives: Behavioral: HDKQ questionnaire
group IIIAll participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status: in group III - first text publications, and then video publications (16 in total).
Receives: Behavioral: HDKQ questionnaire
group IVAll participants will be divided into 4 groups (4 separate accounts), similar in gender, age and social status: in group IV - first video publications, and then text publications (16 in total).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Awareness of risk factors for arterial hypertension as measured by the HDKQ questionnaire

    Measured: Before and after school

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2021
  2. Study start1 Feb 2021
  3. Primary completion21 Feb 2021
  4. Study completion31 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Prospective
Enrolment
125 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04944472
Sponsor's protocol ID
2021/1
Acronym
SocialCor
Status last verified
Jun 2021
First submitted
21 Jun 2021
Last updated
29 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Prevention, Arterial Hypertension, run by Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Awareness of risk factors for arterial hypertension as measured by the HDKQ questionnaire (time frame: Before and after school). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2021; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in